Raymond James Financial
DXCM icon

Raymond James Financial’s DexCom DXCM Stock Holding History

Raymond James Financial’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$300K Buy
+5,000
New +$348K ﹤0.01% 4655

Other funds holding DXCM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Raymond James Financial's DXCM Position: Q1 2026 in Review

Raymond James Financial increased its DexCom (DXCM) stake by 13% in Q1 2026, buying an estimated $23M and bringing the position to 2,782,627 shares worth $174M. The position accounts for 0.05% of the portfolio, ranked #320.

Raymond James Financial first reported a position in DXCM in Q4 2024 and has held it in 6 quarters since. The position peaked at $295M in Q2 2025. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Raymond James Financial held 2,782,627 shares of DexCom worth $174M as of Q1 2026.
  • Raymond James Financial bought 330,415 DexCom shares in Q1 2026, an estimated $23M.
  • DexCom made up 0.05% of Raymond James Financial's portfolio in Q1 2026, its #320 holding.
  • Raymond James Financial first reported a position in DexCom in Q4 2024 and has held it in 6 quarters since.
  • Raymond James Financial's DexCom position peaked at $295M in Q2 2025.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Raymond James Financial's 13F filing for Q1 2026, filed 14 May 2026.